Patent · US Active

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

US7671076B2 · kind B2 · utility

1Cited by

4References

19Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Irini Akritopoulou-Zanze · Libertyville, US
Daria Darczak · Chicago, US
Jurgen Dinges · Wadsworth, US
Stevan W. Djuric · Libertyville, US
Ethan Hoff · Racine, US
Hana Kopecka · Vernon Hills, US
Jyoti R. Patel · Libertyville, US
Zhonghua Pei · South San Francisco, US
Qi Shuai · DeKalb, US
Kathy Sarris · Mundelein, US
Hing L. Sham · South San Francisco, US
Paul E. Wiedeman · Libertyville, US

Key dates

Filing date	Jan 30, 2008
Grant date	Mar 2, 2010
Priority date	—
Expiry date	Apr 3, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/06
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I),which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.